UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The journal of neuropsychiatry and clinical neurosciences, ISSN 0895-0172, 01/2010, Volume 22, Issue 1, pp. 8 - 18
Biological and medical sciences | Neuroprotective agent | Medical sciences | Neuropharmacology | Pharmacology. Drug treatments | Neuroprotective Agents - therapeutic use | Humans | Dopamine Agonists - therapeutic use | Parkinson Disease - drug therapy | Neurodegenerative Diseases - drug therapy | Valproic Acid - pharmacology | Desipramine - pharmacology | Dibenzothiazepines - therapeutic use | Neuroprotective Agents - pharmacology | Desipramine - therapeutic use | Antipsychotic Agents - therapeutic use | Amyloid beta-Peptides - metabolism | Valproic Acid - therapeutic use | Parkinson Disease - metabolism | Clonazepam - therapeutic use | Maprotiline - pharmacology | Dopamine Agonists - pharmacology | Benzodiazepines - pharmacology | Benzothiazoles - pharmacology | Brain - physiopathology | Dibenzothiazepines - pharmacology | Quetiapine Fumarate | Serotonin Uptake Inhibitors - therapeutic use | Alzheimer Disease - drug therapy | Clonazepam - pharmacology | Neurodegenerative Diseases - metabolism | Brain - drug effects | Lithium Carbonate - therapeutic use | Antioxidants - therapeutic use | Neurodegenerative Diseases - physiopathology | Lithium Carbonate - pharmacology | Alzheimer Disease - metabolism | Melatonin - therapeutic use | Benzothiazoles - therapeutic use | Maprotiline - therapeutic use | Antipsychotic Agents - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Benzodiazepines - therapeutic use
Journal Article
The journal of neuropsychiatry and clinical neurosciences, ISSN 0895-0172, 12/2010, Volume 22, Issue 1, pp. 8 - 18
Journal Article
Naunyn-Schmiedeberg's archives of pharmacology, ISSN 0028-1298, 7/2011, Volume 384, Issue 1, pp. 59 - 70
Protein kinase A | Neurosciences | Glutamate release | Cerebral cortex | Biomedicine | Idebenone | Ca v 2.2 (N-type) and Ca v 2.1 (P/Q-type) channels | Synaptosomes | Pharmacology/Toxicology | 2.1 (P/Q-type) channels | 2.2 (N-type) and Ca | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Synaptosomes - drug effects | Calcium Channels - metabolism | Maleimides - pharmacology | Male | Nerve Endings - metabolism | Synaptosomes - metabolism | omega-Conotoxins | Cerebral Cortex - cytology | Calcium - deficiency | Ubiquinone - pharmacology | Dose-Response Relationship, Drug | Calcium - antagonists & inhibitors | Isoquinolines - pharmacology | Macrolides - pharmacology | Indoles - pharmacology | Sodium-Calcium Exchanger - antagonists & inhibitors | Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors | 4-Aminopyridine - pharmacology | Cyclic AMP-Dependent Protein Kinases - metabolism | Membrane Potentials - drug effects | Calcium - pharmacology | Clonazepam - analogs & derivatives | Ubiquinone - analogs & derivatives | Enzyme Inhibitors - pharmacology | Clonazepam - pharmacology | Rats | Protein Kinase C - antagonists & inhibitors | Thiazepines - pharmacology | Dantrolene - pharmacology | Calcium Channel Blockers - pharmacology | Potassium - pharmacology | Sulfonamides - pharmacology | Rats, Sprague-Dawley | Glutamate Plasma Membrane Transport Proteins - antagonists & inhibitors | Pyrroles - pharmacology | Animals | Calcium Signaling - drug effects | Nerve Endings - drug effects | Glutamic Acid - metabolism | Protein Kinase Inhibitors - pharmacology | Carbazoles - pharmacology | Aspartic Acid - pharmacology | Brain | Amino acids | Glutamate | Protein kinases | Nerve endings | Calcium (intracellular) | Calcium channels (N-type) | Calcium channels (voltage-gated) | Cortex | Potassium channels | Calcium influx | Calcium channels (Q-type) | Glutamic acid transporter | Membrane potential | vesicular transporters | Calcium (extracellular) | Na super(+)/Ca super(2+)-exchanging ATPase | Index Medicus
Journal Article
Psychopharmacology, ISSN 0033-3158, 3/2016, Volume 233, Issue 6, pp. 1087 - 1096
Brain | Neurosciences | Endocannabinoid system | Biomedicine | Rat | Resveratrol | Nerve growth factor | Pharmacology/Toxicology | Psychiatry | Pharmacology & Pharmacy | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Endocannabinoids - metabolism | Nerve Growth Factor - metabolism | Rats, Wistar | Bornanes - pharmacology | Clonazepam - pharmacology | Rats | Male | Antioxidants - pharmacology | Stilbenes - pharmacology | Cannabinoids - pharmacology | Brain - drug effects | Brain - metabolism | Dose-Response Relationship, Drug | Animals | Piperidines - pharmacology | Signal Transduction - drug effects | Receptor, Cannabinoid, CB2 | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Amitriptyline - pharmacology | Pyrazoles - pharmacology | Physiological aspects | Cannabinoids | Psychoses | Health aspects | Growth factors | Polyphenols | Neuropsychology | Psychopharmacology | Neurobiology | Index Medicus
Journal Article
Life sciences (1973), ISSN 0024-3205, 12/2019, Volume 239, p. 117033
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Benzodiazepines - pharmacology | GABA Modulators - toxicity | Clonazepam - pharmacology | Motor Activity - drug effects | Male | Zebrafish | Bicuculline - pharmacology | Flumazenil - toxicity | GABA Antagonists - pharmacology | Dose-Response Relationship, Drug | Flumazenil - pharmacology | Animals | Benzodiazepines - toxicity | Larva | GABA Modulators - pharmacology | Receptors, GABA-A - drug effects | Female | Azides - pharmacology | Benzodiazepines - metabolism | Binding Sites - drug effects
Journal Article
Toxicology in vitro, ISSN 0887-2333, 10/2014, Volume 28, Issue 7, pp. 1274 - 1279
Drugs | Erythrocyte | Membrane | Echinocyte | Stomatocyte | Life Sciences & Biomedicine | Toxicology | Science & Technology | Phenobarbital - pharmacology | Microscopy, Electron, Scanning | Citalopram - pharmacology | Humans | Erythrocytes - ultrastructure | Clonazepam - pharmacology | Chlorpromazine - pharmacology | Clomipramine - pharmacology | Valproic Acid - pharmacology | Diazepam - pharmacology | Erythrocytes - drug effects | Injections | Neurotransmitter Agents - pharmacology | Piracetam - analogs & derivatives | Central Nervous System Agents - pharmacology | Erythrocytes - metabolism | Piracetam - pharmacology | Erythrocytes - cytology | Phenytoin - pharmacology | Antidepressants | Drug interactions | Index Medicus
Journal Article
The Journal of physiology, ISSN 0022-3751, 05/2004, Volume 556, Issue 3, pp. 755 - 771
Calcium-Transporting ATPases - antagonists & inhibitors | Cyclosporine - pharmacology | Calcium Signaling - physiology | Sarcoplasmic Reticulum - physiology | Calcium-Binding Proteins - antagonists & inhibitors | Male | Ion Channels - physiology | Diltiazem - pharmacology | Mitochondrial Membrane Transport Proteins | Oligomycins - pharmacology | Carbonyl Cyanide m-Chlorophenyl Hydrazone - pharmacology | Rotenone - pharmacology | Caffeine - pharmacology | Mitochondria, Muscle - physiology | Female | Sodium-Calcium Exchanger - antagonists & inhibitors | Rhodamines - chemistry | Myocytes, Smooth Muscle - drug effects | Cerebral Arteries - cytology | Membrane Potentials - drug effects | Calcium Channels | Clonazepam - analogs & derivatives | Cells, Cultured | Hydrogen Peroxide - pharmacology | Myocytes, Smooth Muscle - physiology | Clonazepam - pharmacology | Rats | Bongkrekic Acid - pharmacology | Thiazepines - pharmacology | Cerebral Arteries - physiology | Calcium Channel Blockers - pharmacology | Rats, Sprague-Dawley | Ion Channels - antagonists & inhibitors | Indazoles - pharmacology | Microscopy, Confocal | Patch-Clamp Techniques | Animals | Calcium Signaling - drug effects | Ion Channels - agonists | Thapsigargin - pharmacology | Mitochondria, Muscle - drug effects | Ruthenium Compounds - pharmacology | Index Medicus | Research Papers
Journal Article
American Journal of Physiology: Cell Physiology, ISSN 0363-6143, 08/2012, Volume 303, Issue 3, pp. C244 - C256
Mitochondrial calcium uniporter | Mitochondrial sodium-calcium exchange | Bronchial smooth muscle | Sarcoplasmic reticulum | Lung | Inflammation | Calcium regulation | Physiology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Calcium - metabolism | Heterocyclic Compounds, 3-Ring - pharmacology | Calcium Signaling - physiology | Humans | Calcium - analysis | Bronchi - drug effects | Inflammation - metabolism | Inflammation - drug therapy | Bronchi - metabolism | Sodium-Calcium Exchanger - antagonists & inhibitors | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - metabolism | Xanthenes - pharmacology | Aniline Compounds - pharmacology | Histamine - pharmacology | Clonazepam - analogs & derivatives | Cells, Cultured | Clonazepam - pharmacology | Mitochondria - metabolism | Thiazepines - pharmacology | Mitochondria - drug effects | Interleukin-13 - pharmacology | Tumor Necrosis Factor-alpha - pharmacology | Microscopy, Fluorescence - methods | Calcium Signaling - drug effects | Ruthenium Compounds - pharmacology | Index Medicus | lung | calcium regulation | inflammation | bronchial smooth muscle | mitochondrial sodium-calcium exchange | mitochondrial calcium uniporter | sarcoplasmic reticulum
Journal Article
Journal of clinical psychopharmacology, ISSN 0271-0749, 04/2017, Volume 37, Issue 2, pp. 246 - 249
memantine | bipolar disorder | obsessive compulsive symptoms | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Outcome Assessment (Health Care) | Humans | Middle Aged | Male | Lithium Compounds - pharmacology | GABA Modulators - pharmacology | Adult | Female | Drug Therapy, Combination | Memantine - administration & dosage | Obsessive-Compulsive Disorder - etiology | Clonazepam - administration & dosage | Memantine - pharmacology | Adjuvants, Pharmaceutic | Benzodiazepines - pharmacology | Antimanic Agents - pharmacology | Double-Blind Method | GABA Modulators - administration & dosage | Clonazepam - pharmacology | Excitatory Amino Acid Antagonists - administration & dosage | Bipolar Disorder - complications | Excitatory Amino Acid Antagonists - pharmacology | Antimanic Agents - administration & dosage | Bipolar Disorder - drug therapy | Antipsychotic Agents - administration & dosage | Obsessive-Compulsive Disorder - drug therapy | Benzodiazepines - administration & dosage | Antipsychotic Agents - pharmacology | Lithium Compounds - administration & dosage | Index Medicus
Journal Article
Journal of neurophysiology, ISSN 0022-3077, 09/2014, Volume 112, Issue 6, pp. 1246 - 1255
Cochlear implants | Mitochondria | Neuroprostheses | Optical stimulation | Calcium photocontrol | Infrared radiation | Vestibular | Neurosciences | Physiology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurons, Afferent - drug effects | Neurons, Afferent - radiation effects | Spiral Ganglion - radiation effects | Temperature | Clonazepam - analogs & derivatives | Calcium Signaling - radiation effects | Cells, Cultured | Clonazepam - pharmacology | Rats | Sodium Channel Blockers - pharmacology | Mitochondria - metabolism | Thiazepines - pharmacology | Calcium Channel Blockers - pharmacology | Rats, Sprague-Dawley | Spiral Ganglion - cytology | Vestibular Nerve - cytology | Animals | Ruthenium Red - pharmacology | Infrared Rays | Indoles - pharmacology | Neurons, Afferent - metabolism | Potassium Channel Blockers - pharmacology | Ryanodine - pharmacology | Vestibular Nerve - radiation effects | Index Medicus | optical stimulation | neuroprostheses | mitochondria | Cellular and Molecular Properties of Neurons | infrared radiation | cochlear implants | vestibular | calcium photocontrol
Journal Article
Experimental neurology, ISSN 0014-4886, 09/2013, Volume 247, pp. 91 - 100